Citadel Advisors - CHECKPOINT THERAPEUTICS INC ownership

CHECKPOINT THERAPEUTICS INC's ticker is and the CUSIP is 162828206. A total of 39 filers reported holding CHECKPOINT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.27 and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of CHECKPOINT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$44,877
-49.9%
26,398
-27.2%
0.00%
Q2 2023$89,562
-16.7%
36,260
-24.1%
0.00%
Q1 2023$107,460
-33.4%
47,760
+51.2%
0.00%
Q4 2022$161,44531,5940.00%
Other shareholders
CHECKPOINT THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
PVG ASSET MANAGEMENT CORP 111,025$188,7421.29%
SABBY MANAGEMENT, LLC 205,247$348,9200.26%
ARMISTICE CAPITAL, LLC 2,064,000$3,508,8000.05%
Legacy Wealth Asset Management, LLC 85,000$144,5000.05%
EMFO, LLC 15,715$26,7160.02%
IRONWOOD INVESTMENT MANAGEMENT LLC 12,801$21,7620.01%
XTX Topco Ltd 20,941$35,6000.01%
Ethos Financial Group, LLC 12,060$20,5020.01%
B. Riley Wealth Advisors, Inc. 49,150$83,5550.00%
PARK AVENUE SECURITIES LLC 59,932$1020.00%
View complete list of CHECKPOINT THERAPEUTICS INC shareholders